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Schizophrenia-derived GPCs exhibit aberrant dispersal in vivo
The dispersal patterns of GPCs produced from SCZ patients typically differed from that of iPSC hGPCs derived from normal patients, in that SCZ GPCs did not remain and expand within the white matter before progressing to cortical infiltration, as was otherwise invariably the case with 
Heat maps of significantly dysregulated genes in schizophrenic relative to control hiPSC GPCs
Expression patterns for shared genes differentially expressed by hiPSC GPCs derived from 4 schizophrenic patients, relative to the pooled gene expression pattern of hGPCs derived from 3 control-derived iPSCs (log2 fold change >1.0, FDR 5%, 118 genes total). The dysregulated genes were manually annotated and grouped into relevant sets based on their function and cellular localization. Each heat map visualizes UQ-normalized, log2-transformed counts of genes grouped into the following functional categories, comprising genes encoding: (A) transcription regulators, zinc finger proteins, and other nucleus-associated proteins; (B) glial differentiation-associated proteins; (C) myelin-related genes and transcription factors; (D) Wnt pathway effectors; (E) metabolic enzymes; (F) lipid and lipoprotein metabolism; (G) kinases and phosphatases; (H) adhesion molecules, cadherins; and astrotactins; (I) GPCR signal intermediates; (J) growth factors; and (K) cytokines. Figure S4 (related to Figure 4) Additional heat maps of significantly dysregulated genes in SCZ relative to control hGPCs Additional heat maps of significantly dysregulated genes in SCZ relative to control hGPCs As in Figure S3 , expression patterns for genes differentially expressed by hiPSC GPCs derived from 4 SCZ patients, relative to the pooled gene expression pattern of hGPCs derived from 3 control-derived iPSCs (log2-fold change >1.0, FDR 5%, 118 genes total). As in Figure S3 , which is derived from the same data set, each heat map visualizes UQ-normalized, log2-transformed counts of differentially expressed genes. These are grouped into the following functional categories, which follow those listed in Figure A total of 11 new independent iPS cell lines were derived from 8 subjects; 5 juvenile-onset schizophrenic patients and 3 healthy controls; an established control line (C27) from an additional normal subject was published previously (Chambers et al., 2009; Wang et al., 2013) , and graciously provided by L. Studer. hGPCs derived from these cells were assigned to individual experiments as noted. C, Caucasian; AA, African-American; NA, not available.
Table S2 (related to Figure 4)
Significantly dysregulated genes in schizophrenic relative to control GPCs These tables list shared genes differentially expressed by hiPSC GPCs derived from 4 SCZ patients, relative to the pooled gene expression pattern of hGPCs from 3 control-derived iPSCs (log2 fold change >1.0, FDR 5%, 116 genes total, red, upregulated in SCZ vs CTRL; green, downregulated in SCZ GPCs). The fold-changes (FC) and FDR-adjusted p values shown here were derived from the comparison of the pooled SCZ-derived GPC lines to the pooled control-derived GPC lines. Dysregulated genes were grouped into functional sets by their cellular roles and localizations. Figure 5 )
Significantly dysregulated synaptic genes in SCZ GPCs
Genomic analysis of SCZ-derived hGPCs from 4 different patients revealed the significant and shared down-regulation in these cells of a number of synaptic genes, including neuroligin-3, neuroexophilin-1, LINGO1 and DSCAML1, relative to their normal controls (red, upregulated in SCZ vs CTRL; green, downregulated in SCZ GPCs; color intensity proportionate to differential dysregulation). Other synapse-associated genes, such as the SLITRKs 2-5, were significantly and sharply downregulated in GPCs derived from 3 of the 4 patients (lines 8, 51 and 164). 
